What is the revenue and EPS growth rate for Owens & Minor year over year?

What does Owens & Minor do and what are its main business segments?

What is Owens & Minor's latest dividend and current dividend yield?

What factors drove the changes in Owens & Minor's revenue and profit?

What were the key takeaways from Owens & Minor’s earnings call?

Did Owens & Minor beat or miss consensus estimates last quarter?

What is the market's earnings forecast for Owens & Minor next quarter?

What is Owens & Minor's gross profit margin?

- **Strategic Restructuring**: Sold P&HS segment to Platinum Equity, repositioning as pure-play home-based care company with $2.1B net debt.
- **Patient Direct Growth**: 3.4% YTD revenue growth in Q3 2025, driven by sleep therapy and diabetes adherence programs.
- **Optum Partnership**: New preferred provider agreement targets 100,000+ healthcare providers, positioning to offset 2026 Kaiser contract loss.
- **Financial Health**: 2025 free cash flow of $78M (YTD), with 2026 outlook improving post-divestiture and stranded cost reduction.
- **Market Opportunity**: 96M prediabetic patients and 85M undiagnosed sleep apnea patients represent secular growth tailwinds.

**【CEO Opening Remarks】**
- Announced definitive agreement to sell Products & Healthcare Services (P&HS) segment to Platinum Equity, retaining equity stake. Rebranding as a pure-play home-based care company post-divestiture in Q1 2026.
- Patient Direct segment will focus on high-margin chronic care (diabetes, sleep apnea), with 37M diabetes patients and 85M undiagnosed sleep apnea patients in the U.S.
- Strategic investments in AI, automation, and cost reduction to improve patient experience and scale operations.
- Signed preferred provider agreement with Optum, leveraging 450 sales reps to target 100,000+ referral sources.

**【CFO Financial Commentary】**
- Q3 2025 revenue: $697M (3.4% YTD growth), driven by sleep therapy, ostomy, and urology. Adjusted EBITDA: $92M (down 15% YoY due to one-time $6M benefit in 2024).
- Full-year 2025 guidance: Revenue $2.76-2.82B, adjusted EBITDA $376-382M, adjusted EPS $1.02-1.07.
- Net debt: $2.1B (includes $100M Rotech exit costs and P&HS kitting facility overstock). Free cash flow from continuing ops: $28M (Q3) / $78M (YTD).

**【Q&A Highlights】**
- **2026 Outlook**: CEO expects strong organic growth in home-based care, offsetting loss of unprofitable Kaiser contract. CFO notes 2026 free cash flow will improve with stranded costs reduction.
- **Optum Agreement**: Early-stage, with potential to replace lost Kaiser margins with fewer new contracts.
- **P&HS Cash Flow Issues**: $100M+ inventory overstock for new kitting facility, expected to normalize in Q1 2026.
- **Balance Sheet Risk**: No covenant breaches; comfortably compliant with lenders.
- **Preferred Provider Agreements**: Focus on high-margin chronic care, with 96M prediabetic patients as growth opportunity.

Owens & Minor, Inc. (OMI) Q3 2025 Earnings Call Transcript

Revenue

Sales and Services Revenue

Financing Services Revenue

Other Revenue

Cost of Revenue

Cost of Goods and Services

Cost of Financing Services

Other Cost

Gross Profit

Other Operating Income

Operating Expenses

Selling, General and Administrative Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research and Development Expenses

Loss on Bad Debts

Loss on Impairment of Other Assets

Loss on Disposal of Assets

Other Operating Expenses

Operating Income

Non-Operating Income (Loss)

Income (Loss) from Affiliates

Income (Loss) from Associates

Income (Loss) from Joint ventures

Gain (Loss) on Other Investment

Gain (Loss) on Change in Fair Value

Gain (Loss) on Foreign Currency Exchange

Other Non-Operating Income (Loss)

Net Interest Expense

Interest Expense

Interest Income

Pretax Income From Continuing Operations

Income Tax Expense

Current Income Tax

Deferred Income Tax

Income Tax Adjustments

Net Income from Continuing Operations

Income from Discontinued Operations

Other Items Before Net Income

Net Income

Net Income Attributable to Minority Interests

Net Income Attributable to Owners of the Company

Preferred Stock Dividends

Other Adjustments

Net Income Attributable to Common Stockholders

Other Comprehensive Income

Total Comprehensive Income

Total Comprehensive Income Attributable to Minority Interests

Total Comprehensive Income Attributable to Owners of the Company

Basic EPS

Basic EPS from Continuing Operations

Basic EPS from Discontinued Operations

Diluted EPS

Diluted EPS from Continuing Operations

Diluted EPS from Discontinued Operations

OMI

OMI fundamentals

You can ask Aime